Early Stage Partners provides early stage venture capital financing to the Midwest’s most promising entrepreneurial companies in:

  • Information Technology
  • Healthcare Technologies
  • Advanced Manufacturing and Industrial Technologies

Early Stage Partners provides early stage venture capital financing to the Midwest’s most promising entrepreneurial companies in:

  • Information Technology
  • Healthcare Technologies
  • Advanced Manufacturing and Industrial Technologies

Early Stage Partners provides early stage venture capital financing to the Midwest’s most promising entrepreneurial companies in:

  • Information Technology
  • Healthcare Technologies
  • Advanced Manufacturing and Industrial Technologies

Early Stage Partners provides early stage venture capital financing to the Midwest’s most promising entrepreneurial companies in:

  • Information Technology
  • Healthcare Technologies
  • Advanced Manufacturing and Industrial Technologies

Early Stage Partners provides early stage venture capital financing to the Midwest’s most promising entrepreneurial companies in:

  • Information Technology
  • Healthcare Technologies
  • Advanced Manufacturing and Industrial Technologies

Early Stage Partners provides early stage venture capital financing to the Midwest’s most promising entrepreneurial companies in:

  • Information Technology
  • Healthcare Technologies
  • Advanced Manufacturing and Industrial Technologies

Mission

Information Technology

Healthcare Technologies

Advanced Manufacturing and Industrial Technologies

Early Stage Partners was formed in 2001 with the belief that the Midwest would create and attract a significant number of companies that would be attractive early stage venture capital investments.

Since then, that belief has been borne out. The Midwest is in the midst of a surge of entrepreneurial energy that is generating high quality technologies and companies. We are pleased to work with the region’s leading entrepreneurs to provide financing, advice, and access to value-added networks.

With a track record of successful investing, ESP is now investing from Fund II.

Find Out More About ESP

News & Events

Juventas Therapeutics, Inc.


February 04, 2016

1st patient in Phase 2 Trial for Treatment of Advanced Peripheral Artery Disease

Blue Spark Technologies


December 16, 2015

Temp Traq is changing the way parents and childcare professionals monitor a baby's temperature through modern technology.

Arisdyne and ExxonMobil Sign Agreement


January 07, 2015

Arisdyne and ExxonMobil Research and Engineering Company Sign Agreement to Develop and Commercialize Cavitation Technology for Petroleum Industry

Covidien Acquires Reverse Medical


August 25, 2014

Covidien acquires Reverse Medical for its endovascular product line.